Patents by Inventor Yves Guyon-Gellin

Yves Guyon-Gellin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 1,1-and 1,2-Bisphosphonates as apoliprotein e modulators
    Publication number: 20060205692
    Abstract: The present invention relates to methods of use 1,1- and 1,2-bisphosphonate compounds to modulate apolipoprotein E levels and use of such compounds in therapy, including cardiovascular and neurological disease states.
    Type: Application
    Filed: May 9, 2003
    Publication date: September 14, 2006
    Inventors: Imber Montes, Hieu Pham, Lan Nguyen, Vinh Diep, Emanuele Burattini, Carlo Severi, Eric Neisor, Anne Perez, Jean-Luc Thuillard, Yves Guyon-Gellin, Craig Bentzen
  • Compounds and pharmaceutical compositions containing them
    Patent number: 6660724
    Abstract: Aminophosphonates alpha substituted by phenol groups of formula (I) have lipoprotein(a) lowering activity.
    Type: Grant
    Filed: April 3, 2000
    Date of Patent: December 9, 2003
    Assignee: Ilex Products, Inc.
    Inventors: Lan Mong Nguyen, Eric Niesor, Craig Leigh Bentzen, Hieu Trung Phan, Vinh Van Diep, Simon Floret, Raymond Azoulay, Alexandre Bulla, Yves Guyon-Gellin, Robert John Ife
  • Compounds and pharmaceutical compositions containing them
    Patent number: 6060464
    Abstract: Aminophosphonates alpha substituted by phenol groups of formula (I) have lipoprotein(a) lowering activity.
    Type: Grant
    Filed: April 3, 1998
    Date of Patent: May 9, 2000
    Assignees: SmithKline Beecham p.l.c., Symphar SA
    Inventors: Lan Mong Nguyen, Eric Niesor, Craig Leigh Bentzen, Hieu Trung Phan, Vinh Van Diep, Simon Floret, Raymond Azoulay, Alexandre Bulla, Yves Guyon-Gellin, Robert John Ife
  • Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them
    Patent number: 5424303
    Abstract: The present invention relates to novel aminophosphonate derivatives substituted in .alpha. position by phenol groups, of formula (I): ##STR1## in which: X.sup.1, X.sup.2, X.sup.3, R.sup.1, R.sup.2, A, B, Z and n are defined in claim 1, as well as their preparations and the pharmaceutical compositions comprising them.
    Type: Grant
    Filed: February 26, 1993
    Date of Patent: June 13, 1995
    Assignee: Symphar SA
    Inventors: Hieu T. Phan, Lan M. Nguyen, Eric Niesor, Yves Guyon-Gellin, Craig L. Bentzen
  • Certain 2-substituted 1,3-propylidenediphosphonate derivatives, pharmaceutical compositions containing them and their use as antihypertensive agents
    Patent number: 4696920
    Abstract: 2-Substituted-1,3-propylidenediphosphonates of formula (I), where A, R.sup.1 and R.sup.2 are defined in claim 1, are therapeutically active compounds, namely for the treatment of cardiovascular diseases.They can be prepared by reacting phosphonating agents with 1,3- dibromopropanes or ditosylates of 1,3-propanediols substituted in position 2. ##STR1## .
    Type: Grant
    Filed: July 16, 1985
    Date of Patent: September 29, 1987
    Assignee: Symphar S.A.
    Inventors: Craig L. Bentzen, Yves Guyon-Gellin, Kyriacos Kalathakis, Hieu T. Phan, Lan Nguyen Mong, Eric Niesor, Jean-Robert Rossier